Jared Whitlock
Reporter
Phone: 858-634-4636 Extension: 3130
Recent Stories
Retrophin’s Stock Tumbles After Miss in Late-Stage Clinical Trial
Shares of Retrophin fell 27% after its rare disease drug candidate failed to work better than a placebo in a late-stage clinical study.
California Life Sciences Association Adds 9 Board Members
The California Life Sciences Association on Aug. 20 announced that it added nine board members, including from Amgen, DuPont Nutrition & Biosciences and Ernst & Young.
Heron’s Pain Anesthetic Successful in Late-Stage Clinical Trial
A postoperative pain anesthetic from Heron Therapeutics reduced pain intensity and the use of opioids among hernia surgery patients in a late-stage clinical trial, the company reported Aug. 20.
Scripps Mercy to Get $59 Million Cancer Center
Prebys Cancer Center Will Be Under Partnership With MD Anderson
SBP Lands $4.96M Grant In Hopes of Helping Oxygen-Deprived Newborns
A professor at Sanford Burnham Prebys Medical Discovery Institute landed a $4.96 million grant to further study a preclinical program for oxygen-deprived newborns at risk of neurological disorders.
Organovo Exploring Strategic Alternatives After Poor Results
Company Suspended Development Of Its Lead Program
SBP and Eli Lilly Extend Collaboration For 3 More Years
Complementary Expertise Being Applied to Develop Immunological Therapies
Ra Medical Announces Leadership Change
BIOTECH: CEO Irwin Is Out; CFO Jackson Named Interim Leader
Ra Medical Announces Leadership Change, Delays Results
BIOTECH: CEO Irwin Is Out; CFO Jackson Named Interim Leader
Amid legal, manufacturing and financial problems Ra Medical Systems delayed the release of second quarter results.
Biotechs (And Other Small Companies) May Lose Association Insurance Option
In a July letter to insurers the California Department of Managed Care, or CDMC, fired a warning shot against association health plans, in what could have wide-reaching impacts for biotechs, life sciences trade groups and other industries.
